

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.66957121 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.66957121 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.60831478 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.60831478 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.00781971 |
| 6 | glyoxylate metabolic process (GO:0046487) | 5.73221409 |
| 7 | sulfur amino acid catabolic process (GO:0000098) | 5.63311953 |
| 8 | alpha-linolenic acid metabolic process (GO:0036109) | 5.44535524 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.44410298 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.44410298 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.44410298 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.43859789 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.38136639 |
| 14 | lysine metabolic process (GO:0006553) | 5.27338630 |
| 15 | lysine catabolic process (GO:0006554) | 5.27338630 |
| 16 | cysteine metabolic process (GO:0006534) | 5.26365257 |
| 17 | bile acid biosynthetic process (GO:0006699) | 5.20890786 |
| 18 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.08474732 |
| 19 | tryptophan metabolic process (GO:0006568) | 5.07998285 |
| 20 | serine family amino acid catabolic process (GO:0009071) | 4.88823339 |
| 21 | urea cycle (GO:0000050) | 4.84225741 |
| 22 | urea metabolic process (GO:0019627) | 4.84225741 |
| 23 | amino-acid betaine metabolic process (GO:0006577) | 4.76631000 |
| 24 | bile acid metabolic process (GO:0008206) | 4.57346982 |
| 25 | regulation of triglyceride catabolic process (GO:0010896) | 4.54654129 |
| 26 | homocysteine metabolic process (GO:0050667) | 4.54412312 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 4.53562080 |
| 28 | acetyl-CoA metabolic process (GO:0006084) | 4.53296165 |
| 29 | complement activation, alternative pathway (GO:0006957) | 4.51692617 |
| 30 | high-density lipoprotein particle remodeling (GO:0034375) | 4.44968705 |
| 31 | protein carboxylation (GO:0018214) | 4.43387097 |
| 32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.43387097 |
| 33 | fatty acid beta-oxidation (GO:0006635) | 4.42796765 |
| 34 | cellular ketone body metabolic process (GO:0046950) | 4.42569906 |
| 35 | negative regulation of fibrinolysis (GO:0051918) | 4.42375176 |
| 36 | triglyceride homeostasis (GO:0070328) | 4.41989866 |
| 37 | acylglycerol homeostasis (GO:0055090) | 4.41989866 |
| 38 | regulation of protein activation cascade (GO:2000257) | 4.41553726 |
| 39 | alpha-amino acid catabolic process (GO:1901606) | 4.39846414 |
| 40 | aromatic amino acid family metabolic process (GO:0009072) | 4.38185725 |
| 41 | regulation of fibrinolysis (GO:0051917) | 4.25029902 |
| 42 | cellular amino acid catabolic process (GO:0009063) | 4.19406288 |
| 43 | fatty acid oxidation (GO:0019395) | 4.17422221 |
| 44 | short-chain fatty acid metabolic process (GO:0046459) | 4.15139222 |
| 45 | regulation of complement activation (GO:0030449) | 4.13436013 |
| 46 | lipid oxidation (GO:0034440) | 4.10357403 |
| 47 | fatty acid catabolic process (GO:0009062) | 4.07164435 |
| 48 | tyrosine metabolic process (GO:0006570) | 4.05759864 |
| 49 | aspartate family amino acid catabolic process (GO:0009068) | 4.04163157 |
| 50 | fatty acid transmembrane transport (GO:1902001) | 4.03094407 |
| 51 | glutamate metabolic process (GO:0006536) | 4.00168927 |
| 52 | 2-oxoglutarate metabolic process (GO:0006103) | 3.99767969 |
| 53 | coenzyme catabolic process (GO:0009109) | 3.97637157 |
| 54 | regulation of cholesterol homeostasis (GO:2000188) | 3.97253716 |
| 55 | ethanol oxidation (GO:0006069) | 3.96936037 |
| 56 | monocarboxylic acid catabolic process (GO:0072329) | 3.93843053 |
| 57 | reverse cholesterol transport (GO:0043691) | 3.93383053 |
| 58 | cellular modified amino acid catabolic process (GO:0042219) | 3.92842152 |
| 59 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.91950552 |
| 60 | carboxylic acid catabolic process (GO:0046395) | 3.89043882 |
| 61 | organic acid catabolic process (GO:0016054) | 3.89043882 |
| 62 | carnitine metabolic process (GO:0009437) | 3.88793309 |
| 63 | serine family amino acid metabolic process (GO:0009069) | 3.88597142 |
| 64 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.88544620 |
| 65 | protein-lipid complex remodeling (GO:0034368) | 3.85958882 |
| 66 | macromolecular complex remodeling (GO:0034367) | 3.85958882 |
| 67 | plasma lipoprotein particle remodeling (GO:0034369) | 3.85958882 |
| 68 | regulation of cholesterol esterification (GO:0010872) | 3.85267427 |
| 69 | plasma lipoprotein particle clearance (GO:0034381) | 3.83379130 |
| 70 | negative regulation of cholesterol transport (GO:0032375) | 3.82826440 |
| 71 | negative regulation of sterol transport (GO:0032372) | 3.82826440 |
| 72 | ketone body metabolic process (GO:1902224) | 3.80862269 |
| 73 | drug catabolic process (GO:0042737) | 3.79203651 |
| 74 | carnitine shuttle (GO:0006853) | 3.78622109 |
| 75 | drug transmembrane transport (GO:0006855) | 3.77287620 |
| 76 | desmosome organization (GO:0002934) | 3.76582968 |
| 77 | benzene-containing compound metabolic process (GO:0042537) | 3.76018900 |
| 78 | indolalkylamine metabolic process (GO:0006586) | 3.73870094 |
| 79 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.72675884 |
| 80 | mannose metabolic process (GO:0006013) | 3.72539799 |
| 81 | cellular glucuronidation (GO:0052695) | 3.71380598 |
| 82 | glycine metabolic process (GO:0006544) | 3.71007626 |
| 83 | cellular biogenic amine catabolic process (GO:0042402) | 3.67203059 |
| 84 | amine catabolic process (GO:0009310) | 3.67203059 |
| 85 | biotin metabolic process (GO:0006768) | 3.65106120 |
| 86 | positive regulation of lipid catabolic process (GO:0050996) | 3.64999834 |
| 87 | regulation of apoptotic cell clearance (GO:2000425) | 3.64727046 |
| 88 | proline metabolic process (GO:0006560) | 3.64539327 |
| 89 | phospholipid efflux (GO:0033700) | 3.63128241 |
| 90 | valine metabolic process (GO:0006573) | 3.60918591 |
| 91 | urate metabolic process (GO:0046415) | 3.59752265 |
| 92 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.59564766 |
| 93 | cholesterol efflux (GO:0033344) | 3.59448562 |
| 94 | cytolysis (GO:0019835) | 3.59247535 |
| 95 | bile acid and bile salt transport (GO:0015721) | 3.58120359 |
| 96 | heme transport (GO:0015886) | 3.50988572 |
| 97 | regulation of bile acid biosynthetic process (GO:0070857) | 3.50165147 |
| 98 | phospholipid homeostasis (GO:0055091) | 3.47678266 |
| 99 | apoptotic process involved in morphogenesis (GO:0060561) | 3.47398719 |
| 100 | plasma lipoprotein particle assembly (GO:0034377) | 3.47268885 |
| 101 | branched-chain amino acid catabolic process (GO:0009083) | 3.44227578 |
| 102 | exogenous drug catabolic process (GO:0042738) | 3.43620842 |
| 103 | cholesterol homeostasis (GO:0042632) | 3.43460732 |
| 104 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.43279034 |
| 105 | cell-cell junction maintenance (GO:0045217) | 3.31494720 |
| 106 | response to mercury ion (GO:0046689) | 3.25643028 |
| 107 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.25201168 |
| 108 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.25201168 |
| 109 | creatine metabolic process (GO:0006600) | 3.25020309 |
| 110 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.21569867 |
| 111 | actin-myosin filament sliding (GO:0033275) | 3.19030328 |
| 112 | muscle filament sliding (GO:0030049) | 3.19030328 |
| 113 | NADH metabolic process (GO:0006734) | 3.18098372 |
| 114 | epithelial cell-cell adhesion (GO:0090136) | 3.04896296 |
| 115 | focal adhesion assembly (GO:0048041) | 3.00819781 |
| 116 | cell-substrate adherens junction assembly (GO:0007045) | 3.00819781 |
| 117 | endothelial cell chemotaxis (GO:0035767) | 2.96924991 |
| 118 | semaphorin-plexin signaling pathway (GO:0071526) | 2.95767916 |
| 119 | regulation of ARF GTPase activity (GO:0032312) | 2.95523466 |
| 120 | low-density lipoprotein particle clearance (GO:0034383) | 2.94865580 |
| 121 | myofibril assembly (GO:0030239) | 2.92567526 |
| 122 | negative regulation of cell size (GO:0045792) | 2.88087797 |
| 123 | adherens junction assembly (GO:0034333) | 2.84959754 |
| 124 | sarcomere organization (GO:0045214) | 2.84400849 |
| 125 | oxaloacetate metabolic process (GO:0006107) | 2.84038414 |
| 126 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.83320093 |
| 127 | basement membrane organization (GO:0071711) | 2.83304280 |
| 128 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.82449412 |
| 129 | barbed-end actin filament capping (GO:0051016) | 2.80020581 |
| 130 | positive regulation of receptor recycling (GO:0001921) | 2.78696811 |
| 131 | cell junction maintenance (GO:0034331) | 2.78035377 |
| 132 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.77625447 |
| 133 | cell volume homeostasis (GO:0006884) | 2.77393476 |
| 134 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.76941762 |
| 135 | fructose metabolic process (GO:0006000) | 2.75390506 |
| 136 | cell-substrate junction assembly (GO:0007044) | 2.72788166 |
| 137 | protein retention in ER lumen (GO:0006621) | 2.72730882 |
| 138 | diacylglycerol metabolic process (GO:0046339) | 2.70502665 |
| 139 | negative regulation of fatty acid transport (GO:2000192) | 2.68764547 |
| 140 | carnitine transmembrane transport (GO:1902603) | 2.66803794 |
| 141 | glucose 6-phosphate metabolic process (GO:0051156) | 2.65557133 |
| 142 | response to muscle activity (GO:0014850) | 2.65440094 |
| 143 | cardiac myofibril assembly (GO:0055003) | 2.63237437 |
| 144 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.62074008 |
| 145 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.61934343 |
| 146 | cardiac muscle contraction (GO:0060048) | 2.59695843 |
| 147 | skeletal muscle contraction (GO:0003009) | 2.57888292 |
| 148 | protein-lipid complex assembly (GO:0065005) | 2.57701947 |
| 149 | activation of Rac GTPase activity (GO:0032863) | 2.56370852 |
| 150 | atrioventricular valve morphogenesis (GO:0003181) | 2.55963871 |
| 151 | actin-mediated cell contraction (GO:0070252) | 2.55341388 |
| 152 | glycogen catabolic process (GO:0005980) | 2.54052712 |
| 153 | amino-acid betaine transport (GO:0015838) | 2.53827130 |
| 154 | carnitine transport (GO:0015879) | 2.53827130 |
| 155 | regulation of cholesterol metabolic process (GO:0090181) | 2.53142070 |
| 156 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.51893245 |
| 157 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.51716473 |
| 158 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.50956046 |
| 159 | acute-phase response (GO:0006953) | 2.50521427 |
| 160 | hemidesmosome assembly (GO:0031581) | 2.49780618 |
| 161 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.49483199 |
| 162 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.49347192 |
| 163 | glucan catabolic process (GO:0009251) | 2.48247792 |
| 164 | proline biosynthetic process (GO:0006561) | 2.46145962 |
| 165 | embryonic process involved in female pregnancy (GO:0060136) | 2.45921073 |
| 166 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.45249346 |
| 167 | regulation of plasminogen activation (GO:0010755) | 2.44628903 |
| 168 | quaternary ammonium group transport (GO:0015697) | 2.44400136 |
| 169 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.43582337 |
| 170 | striated muscle contraction (GO:0006941) | 2.40888280 |
| 171 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.40205592 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.87533219 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.39069714 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.33943068 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.10224898 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.75091861 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.06711283 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.87416673 |
| 8 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.84285230 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.81479465 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.04172680 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.76966617 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.62191193 |
| 13 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.26401753 |
| 14 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.25396887 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.23874545 |
| 16 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.16616875 |
| 17 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.13274045 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.12673588 |
| 19 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.99651485 |
| 20 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.98764264 |
| 21 | KDM2B_26808549_Chip-Seq_K562_Human | 1.90602994 |
| 22 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.87432687 |
| 23 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.84517564 |
| 24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.77384615 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.71662859 |
| 26 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.64806328 |
| 27 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.60127647 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.59982875 |
| 29 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.56118936 |
| 30 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.54231280 |
| 31 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.50661845 |
| 32 | MYC_22102868_ChIP-Seq_BL_Human | 1.49432304 |
| 33 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.49258993 |
| 34 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.45033543 |
| 35 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44792714 |
| 36 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.44222750 |
| 37 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.41895732 |
| 38 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40393902 |
| 39 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.38857763 |
| 40 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.37443562 |
| 41 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.37387452 |
| 42 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.36641271 |
| 43 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.33750215 |
| 44 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.31897423 |
| 45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29179571 |
| 46 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.27809223 |
| 47 | ATF3_27146783_Chip-Seq_COLON_Human | 1.26388452 |
| 48 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.25662527 |
| 49 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.24831731 |
| 50 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.24470370 |
| 51 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.23421380 |
| 52 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.22485856 |
| 53 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.20174763 |
| 54 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.19297988 |
| 55 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.17160846 |
| 56 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.16698342 |
| 57 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.15114403 |
| 58 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.14560770 |
| 59 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.13856336 |
| 60 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12840332 |
| 61 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.12441729 |
| 62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.11672016 |
| 63 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.10970080 |
| 64 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.09210680 |
| 65 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.09018447 |
| 66 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.07174361 |
| 67 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.05182143 |
| 68 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.04018664 |
| 69 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.04018229 |
| 70 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03605090 |
| 71 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.02070507 |
| 72 | MAF_26560356_Chip-Seq_TH2_Human | 0.99789971 |
| 73 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.98165508 |
| 74 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.97817528 |
| 75 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.97075466 |
| 76 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.96596999 |
| 77 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96505001 |
| 78 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.96161146 |
| 79 | SPI1_23127762_ChIP-Seq_K562_Human | 0.95996875 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94468706 |
| 81 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.93919497 |
| 82 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93067150 |
| 83 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.92846738 |
| 84 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.92418037 |
| 85 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.91855920 |
| 86 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.90815965 |
| 87 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.89421173 |
| 88 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.86178138 |
| 89 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.84999884 |
| 90 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.84372183 |
| 91 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.83841069 |
| 92 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82876922 |
| 93 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.81956163 |
| 94 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.81829488 |
| 95 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.80266944 |
| 96 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.79905189 |
| 97 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.79707890 |
| 98 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.79133115 |
| 99 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.78374636 |
| 100 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.77732143 |
| 101 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.76476798 |
| 102 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.76476798 |
| 103 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.76039240 |
| 104 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.74797604 |
| 105 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.74325219 |
| 106 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.72435885 |
| 107 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.72189225 |
| 108 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.71827360 |
| 109 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.70417899 |
| 110 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.69312656 |
| 111 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.68964880 |
| 112 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.67482999 |
| 113 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.67465636 |
| 114 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.67420447 |
| 115 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.66885809 |
| 116 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.65026616 |
| 117 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.64483351 |
| 118 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.64246213 |
| 119 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.63115445 |
| 120 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.63033715 |
| 121 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.62709192 |
| 122 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.61882603 |
| 123 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.60452950 |
| 124 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.60068790 |
| 125 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.60021834 |
| 126 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.59066454 |
| 127 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.59044423 |
| 128 | * P68_20966046_ChIP-Seq_HELA_Human | 0.58802036 |
| 129 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.58733083 |
| 130 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.57485646 |
| 131 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.57049559 |
| 132 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.56755918 |
| 133 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.56318470 |
| 134 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.55928399 |
| 135 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.55556118 |
| 136 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.55504466 |
| 137 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.55350673 |
| 138 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.54931019 |
| 139 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.54801977 |
| 140 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.54403129 |
| 141 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.54301945 |
| 142 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.52918208 |
| 143 | SA1_27219007_Chip-Seq_Bcells_Human | 0.52345547 |
| 144 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.51301981 |
| 145 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.50977114 |
| 146 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.50963616 |
| 147 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.50218866 |
| 148 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.50009638 |
| 149 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.49025594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.46942816 |
| 2 | MP0005360_urolithiasis | 7.06969858 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.96894365 |
| 4 | MP0005365_abnormal_bile_salt | 5.89993508 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.66245500 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.69125025 |
| 7 | MP0003252_abnormal_bile_duct | 3.51090303 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.36416700 |
| 9 | MP0005332_abnormal_amino_acid | 3.13232944 |
| 10 | MP0003195_calcinosis | 2.83194198 |
| 11 | MP0009840_abnormal_foam_cell | 2.73533304 |
| 12 | MP0005083_abnormal_biliary_tract | 2.56629222 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 2.54078343 |
| 14 | MP0004084_abnormal_cardiac_muscle | 2.43580521 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.33735653 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.30273139 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.23023005 |
| 18 | MP0010234_abnormal_vibrissa_follicle | 2.20603181 |
| 19 | MP0005670_abnormal_white_adipose | 2.19595892 |
| 20 | MP0000749_muscle_degeneration | 2.17925021 |
| 21 | MP0000678_abnormal_parathyroid_gland | 2.15473049 |
| 22 | MP0001849_ear_inflammation | 2.10404506 |
| 23 | MP0000609_abnormal_liver_physiology | 2.05943660 |
| 24 | MP0000747_muscle_weakness | 1.90770036 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.84285722 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.82536679 |
| 27 | MP0004510_myositis | 1.82060361 |
| 28 | MP0005076_abnormal_cell_differentiation | 1.76255792 |
| 29 | MP0000013_abnormal_adipose_tissue | 1.75538655 |
| 30 | MP0003566_abnormal_cell_adhesion | 1.72721584 |
| 31 | MP0005409_darkened_coat_color | 1.66197156 |
| 32 | MP0004130_abnormal_muscle_cell | 1.63940755 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.61862199 |
| 34 | MP0006138_congestive_heart_failure | 1.58370658 |
| 35 | MP0000566_synostosis | 1.54790502 |
| 36 | MP0000003_abnormal_adipose_tissue | 1.54207539 |
| 37 | MP0003172_abnormal_lysosome_physiology | 1.54201692 |
| 38 | MP0004858_abnormal_nervous_system | 1.52061596 |
| 39 | MP0001764_abnormal_homeostasis | 1.49961187 |
| 40 | MP0009643_abnormal_urine_homeostasis | 1.49913896 |
| 41 | MP0005666_abnormal_adipose_tissue | 1.44435697 |
| 42 | MP0005410_abnormal_fertilization | 1.43665382 |
| 43 | MP0003705_abnormal_hypodermis_morpholog | 1.41610466 |
| 44 | MP0000759_abnormal_skeletal_muscle | 1.38651954 |
| 45 | MP0005451_abnormal_body_composition | 1.38211839 |
| 46 | MP0002837_dystrophic_cardiac_calcinosis | 1.35597431 |
| 47 | MP0002971_abnormal_brown_adipose | 1.31561291 |
| 48 | MP0004272_abnormal_basement_membrane | 1.28757409 |
| 49 | MP0003879_abnormal_hair_cell | 1.28499828 |
| 50 | MP0004145_abnormal_muscle_electrophysio | 1.28463370 |
| 51 | MP0003868_abnormal_feces_composition | 1.27654429 |
| 52 | MP0008004_abnormal_stomach_pH | 1.26149623 |
| 53 | MP0006036_abnormal_mitochondrial_physio | 1.25409657 |
| 54 | MP0003186_abnormal_redox_activity | 1.24772095 |
| 55 | MP0002108_abnormal_muscle_morphology | 1.21365773 |
| 56 | MP0003878_abnormal_ear_physiology | 1.20788142 |
| 57 | MP0005377_hearing/vestibular/ear_phenot | 1.20788142 |
| 58 | MP0002254_reproductive_system_inflammat | 1.18453453 |
| 59 | MP0008260_abnormal_autophagy | 1.17019527 |
| 60 | MP0002972_abnormal_cardiac_muscle | 1.16591863 |
| 61 | MP0005647_abnormal_sex_gland | 1.15240992 |
| 62 | MP0005620_abnormal_muscle_contractility | 1.09960523 |
| 63 | MP0002106_abnormal_muscle_physiology | 1.09484090 |
| 64 | MP0005369_muscle_phenotype | 1.04868681 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.02731639 |
| 66 | MP0000598_abnormal_liver_morphology | 1.01683226 |
| 67 | MP0002132_abnormal_respiratory_system | 1.01516542 |
| 68 | MP0003436_decreased_susceptibility_to | 1.00894553 |
| 69 | MP0002796_impaired_skin_barrier | 1.00779352 |
| 70 | MP0000467_abnormal_esophagus_morphology | 0.99437692 |
| 71 | MP0000750_abnormal_muscle_regeneration | 0.99275093 |
| 72 | MP0003011_delayed_dark_adaptation | 0.98370643 |
| 73 | MP0000579_abnormal_nail_morphology | 0.96165208 |
| 74 | MP0005636_abnormal_mineral_homeostasis | 0.94752519 |
| 75 | MP0004381_abnormal_hair_follicle | 0.94717271 |
| 76 | MP0005535_abnormal_body_temperature | 0.93813210 |
| 77 | MP0004264_abnormal_extraembryonic_tissu | 0.93639270 |
| 78 | MP0003091_abnormal_cell_migration | 0.92792865 |
| 79 | MP0004043_abnormal_pH_regulation | 0.91088497 |
| 80 | MP0003045_fibrosis | 0.89863382 |
| 81 | MP0005330_cardiomyopathy | 0.89448088 |
| 82 | MP0009278_abnormal_bone_marrow | 0.88434286 |
| 83 | MP0000537_abnormal_urethra_morphology | 0.88321146 |
| 84 | MP0000733_abnormal_muscle_development | 0.88079714 |
| 85 | MP0004947_skin_inflammation | 0.87420161 |
| 86 | MP0005023_abnormal_wound_healing | 0.87083753 |
| 87 | MP0005334_abnormal_fat_pad | 0.86925827 |
| 88 | MP0002078_abnormal_glucose_homeostasis | 0.86923830 |
| 89 | MP0004185_abnormal_adipocyte_glucose | 0.85934801 |
| 90 | MP0001661_extended_life_span | 0.85194893 |
| 91 | MP0000604_amyloidosis | 0.84394599 |
| 92 | MP0001756_abnormal_urination | 0.84122544 |
| 93 | MP0005266_abnormal_metabolism | 0.84046615 |
| 94 | MP0002998_abnormal_bone_remodeling | 0.83410308 |
| 95 | MP0002933_joint_inflammation | 0.81735613 |
| 96 | MP0001544_abnormal_cardiovascular_syste | 0.81527314 |
| 97 | MP0005385_cardiovascular_system_phenoty | 0.81527314 |
| 98 | MP0002269_muscular_atrophy | 0.80868580 |
| 99 | MP0003828_pulmonary_edema | 0.80501722 |
| 100 | MP0005376_homeostasis/metabolism_phenot | 0.79303242 |
| 101 | MP0009642_abnormal_blood_homeostasis | 0.79000011 |
| 102 | MP0002089_abnormal_postnatal_growth/wei | 0.77943395 |
| 103 | MP0009115_abnormal_fat_cell | 0.77147801 |
| 104 | MP0003646_muscle_fatigue | 0.76689462 |
| 105 | MP0005375_adipose_tissue_phenotype | 0.76562753 |
| 106 | MP0009764_decreased_sensitivity_to | 0.75779381 |
| 107 | MP0008438_abnormal_cutaneous_collagen | 0.75227570 |
| 108 | MP0005503_abnormal_tendon_morphology | 0.74482396 |
| 109 | MP0003690_abnormal_glial_cell | 0.73646563 |
| 110 | MP0001873_stomach_inflammation | 0.72353463 |
| 111 | MP0009763_increased_sensitivity_to | 0.71587278 |
| 112 | MP0003329_amyloid_beta_deposits | 0.70065470 |
| 113 | MP0003315_abnormal_perineum_morphology | 0.69445528 |
| 114 | MP0001348_abnormal_lacrimal_gland | 0.68598347 |
| 115 | MP0000767_abnormal_smooth_muscle | 0.68585770 |
| 116 | MP0000858_altered_metastatic_potential | 0.68083246 |
| 117 | MP0009697_abnormal_copulation | 0.66921466 |
| 118 | MP0002136_abnormal_kidney_physiology | 0.64992933 |
| 119 | MP0003279_aneurysm | 0.64803887 |
| 120 | MP0002876_abnormal_thyroid_physiology | 0.63594901 |
| 121 | MP0004233_abnormal_muscle_weight | 0.63093572 |
| 122 | MP0002970_abnormal_white_adipose | 0.62389123 |
| 123 | MP0006035_abnormal_mitochondrial_morpho | 0.62049833 |
| 124 | MP0010368_abnormal_lymphatic_system | 0.61987469 |
| 125 | MP0005448_abnormal_energy_balance | 0.60079857 |
| 126 | MP0000639_abnormal_adrenal_gland | 0.59495476 |
| 127 | MP0008469_abnormal_protein_level | 0.58629166 |
| 128 | MP0002332_abnormal_exercise_endurance | 0.57505337 |
| 129 | MP0002168_other_aberrant_phenotype | 0.57356272 |
| 130 | MP0003453_abnormal_keratinocyte_physiol | 0.56013545 |
| 131 | MP0003638_abnormal_response/metabolism_ | 0.55696865 |
| 132 | MP0005058_abnormal_lysosome_morphology | 0.55445712 |
| 133 | MP0002060_abnormal_skin_morphology | 0.53357228 |
| 134 | MP0005395_other_phenotype | 0.52641783 |
| 135 | MP0003953_abnormal_hormone_level | 0.50768876 |
| 136 | MP0000751_myopathy | 0.50433091 |
| 137 | MP0009053_abnormal_anal_canal | 0.50355365 |
| 138 | MP0008874_decreased_physiological_sensi | 0.49676861 |
| 139 | MP0003075_altered_response_to | 0.49295292 |
| 140 | MP0005220_abnormal_exocrine_pancreas | 0.49114521 |
| 141 | MP0001765_abnormal_ion_homeostasis | 0.46475671 |
| 142 | MP0000230_abnormal_systemic_arterial | 0.44199026 |
| 143 | MP0004087_abnormal_muscle_fiber | 0.43063574 |
| 144 | MP0005084_abnormal_gallbladder_morpholo | 0.40972512 |
| 145 | MP0009765_abnormal_xenobiotic_induced | 0.40810302 |
| 146 | MP0008872_abnormal_physiological_respon | 0.39793286 |
| 147 | MP0004782_abnormal_surfactant_physiolog | 0.39279685 |
| 148 | MP0010630_abnormal_cardiac_muscle | 0.38056720 |
| 149 | MP0008961_abnormal_basal_metabolism | 0.37994625 |
| 150 | MP0008775_abnormal_heart_ventricle | 0.36806725 |
| 151 | MP0002928_abnormal_bile_duct | 0.36737170 |
| 152 | MP0005248_abnormal_Harderian_gland | 0.36705425 |
| 153 | MP0003959_abnormal_lean_body | 0.36256155 |
| 154 | MP0010030_abnormal_orbit_morphology | 0.35946871 |
| 155 | MP0002249_abnormal_larynx_morphology | 0.35509079 |
| 156 | MP0004036_abnormal_muscle_relaxation | 0.34699457 |
| 157 | MP0005501_abnormal_skin_physiology | 0.33163235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.33940986 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.11946746 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.93437935 |
| 4 | Xanthomatosis (HP:0000991) | 5.65237569 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.49196886 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.17463822 |
| 7 | Hyperglycinuria (HP:0003108) | 5.00035458 |
| 8 | Hyperammonemia (HP:0001987) | 4.89211156 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 4.86469017 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.81741165 |
| 11 | Ketosis (HP:0001946) | 4.79253836 |
| 12 | Abnormality of glycine metabolism (HP:0010895) | 4.58946373 |
| 13 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.58946373 |
| 14 | Complement deficiency (HP:0004431) | 4.51643850 |
| 15 | Hyperglycinemia (HP:0002154) | 4.45058086 |
| 16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.34588916 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.24241833 |
| 18 | Ketoacidosis (HP:0001993) | 4.09516777 |
| 19 | Hypoglycemic coma (HP:0001325) | 4.07501936 |
| 20 | Increased connective tissue (HP:0009025) | 4.06782986 |
| 21 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.05870888 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 4.04689227 |
| 23 | Epidermoid cyst (HP:0200040) | 4.02222868 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.88591801 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.86292557 |
| 26 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.78911543 |
| 27 | Distal lower limb muscle weakness (HP:0009053) | 3.75992956 |
| 28 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.65988606 |
| 29 | Joint hemorrhage (HP:0005261) | 3.55314132 |
| 30 | Type 1 muscle fiber predominance (HP:0003803) | 3.54072833 |
| 31 | Asymmetric septal hypertrophy (HP:0001670) | 3.47996052 |
| 32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.46348007 |
| 33 | Abnormality of methionine metabolism (HP:0010901) | 3.45575753 |
| 34 | Gout (HP:0001997) | 3.41127160 |
| 35 | Fat malabsorption (HP:0002630) | 3.35822627 |
| 36 | Right ventricular cardiomyopathy (HP:0011663) | 3.32051871 |
| 37 | Hyporeflexia of lower limbs (HP:0002600) | 3.30699699 |
| 38 | Abnormality of the common coagulation pathway (HP:0010990) | 3.29908487 |
| 39 | Abnormality of complement system (HP:0005339) | 3.27956354 |
| 40 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.22093293 |
| 41 | Dicarboxylic aciduria (HP:0003215) | 3.22093293 |
| 42 | Muscle fiber splitting (HP:0003555) | 3.19211370 |
| 43 | Myopathic facies (HP:0002058) | 3.15034456 |
| 44 | Abnormality of purine metabolism (HP:0004352) | 3.09913244 |
| 45 | Distal lower limb amyotrophy (HP:0008944) | 3.08440934 |
| 46 | Delayed CNS myelination (HP:0002188) | 3.06883976 |
| 47 | Muscle fiber inclusion bodies (HP:0100299) | 3.06083173 |
| 48 | Hypercholesterolemia (HP:0003124) | 3.03414982 |
| 49 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.00726639 |
| 50 | Abnormality of nucleobase metabolism (HP:0010932) | 2.99360474 |
| 51 | Lethargy (HP:0001254) | 2.93231598 |
| 52 | Abnormality of serum amino acid levels (HP:0003112) | 2.93202971 |
| 53 | Metabolic acidosis (HP:0001942) | 2.92396634 |
| 54 | Myocardial infarction (HP:0001658) | 2.88672938 |
| 55 | Cerebral aneurysm (HP:0004944) | 2.88411354 |
| 56 | Myoglobinuria (HP:0002913) | 2.83743806 |
| 57 | Hypochromic microcytic anemia (HP:0004840) | 2.82021314 |
| 58 | Increased variability in muscle fiber diameter (HP:0003557) | 2.81899712 |
| 59 | Bulbar palsy (HP:0001283) | 2.81487384 |
| 60 | Obstructive sleep apnea (HP:0002870) | 2.80180782 |
| 61 | Stridor (HP:0010307) | 2.79505804 |
| 62 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.78254934 |
| 63 | Nemaline bodies (HP:0003798) | 2.76339819 |
| 64 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.75239291 |
| 65 | Sudden death (HP:0001699) | 2.74040350 |
| 66 | Ventricular tachycardia (HP:0004756) | 2.70200125 |
| 67 | Hyperbilirubinemia (HP:0002904) | 2.69764773 |
| 68 | Difficulty climbing stairs (HP:0003551) | 2.68250238 |
| 69 | Abnormality of the intrinsic pathway (HP:0010989) | 2.67784578 |
| 70 | Glomerulonephritis (HP:0000099) | 2.65782038 |
| 71 | Flat acetabular roof (HP:0003180) | 2.62555441 |
| 72 | Generalized aminoaciduria (HP:0002909) | 2.62228119 |
| 73 | Cerebral edema (HP:0002181) | 2.61918746 |
| 74 | Conjugated hyperbilirubinemia (HP:0002908) | 2.57010489 |
| 75 | EMG: myopathic abnormalities (HP:0003458) | 2.54495975 |
| 76 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.53520735 |
| 77 | Increased purine levels (HP:0004368) | 2.51225639 |
| 78 | Hyperuricemia (HP:0002149) | 2.51225639 |
| 79 | Steatorrhea (HP:0002570) | 2.50766242 |
| 80 | Skin nodule (HP:0200036) | 2.50478161 |
| 81 | Malnutrition (HP:0004395) | 2.49716517 |
| 82 | Vascular calcification (HP:0004934) | 2.49628675 |
| 83 | Diaphragmatic weakness (HP:0009113) | 2.49405084 |
| 84 | Hydroxyprolinuria (HP:0003080) | 2.48499147 |
| 85 | Abnormality of proline metabolism (HP:0010907) | 2.48499147 |
| 86 | Spinal rigidity (HP:0003306) | 2.44219109 |
| 87 | Turricephaly (HP:0000262) | 2.43950541 |
| 88 | Neonatal onset (HP:0003623) | 2.41029797 |
| 89 | Proximal tubulopathy (HP:0000114) | 2.40674305 |
| 90 | Axonal loss (HP:0003447) | 2.40351898 |
| 91 | Hepatocellular carcinoma (HP:0001402) | 2.39016866 |
| 92 | Broad face (HP:0000283) | 2.38293723 |
| 93 | * Vomiting (HP:0002013) | 2.35149114 |
| 94 | Thoracic kyphosis (HP:0002942) | 2.33653185 |
| 95 | Irritability (HP:0000737) | 2.31668063 |
| 96 | Neck muscle weakness (HP:0000467) | 2.30404474 |
| 97 | Cervical subluxation (HP:0003308) | 2.28559181 |
| 98 | Easy fatigability (HP:0003388) | 2.28408064 |
| 99 | Abnormality of the thoracic spine (HP:0100711) | 2.26868370 |
| 100 | Difficulty running (HP:0009046) | 2.26797888 |
| 101 | Reticulocytosis (HP:0001923) | 2.24995467 |
| 102 | Cholelithiasis (HP:0001081) | 2.24407843 |
| 103 | Alkalosis (HP:0001948) | 2.24208879 |
| 104 | Abnormality of the calf musculature (HP:0001430) | 2.23354750 |
| 105 | Spontaneous abortion (HP:0005268) | 2.23346696 |
| 106 | Cardiovascular calcification (HP:0011915) | 2.23183203 |
| 107 | Spastic diplegia (HP:0001264) | 2.22516050 |
| 108 | Thin bony cortex (HP:0002753) | 2.21380248 |
| 109 | Abnormal gallbladder morphology (HP:0012437) | 2.20784579 |
| 110 | Abnormality of the Achilles tendon (HP:0005109) | 2.18767978 |
| 111 | Ulnar bowing (HP:0003031) | 2.17903899 |
| 112 | Late onset (HP:0003584) | 2.16347871 |
| 113 | Abnormal gallbladder physiology (HP:0012438) | 2.15427669 |
| 114 | Cholecystitis (HP:0001082) | 2.15427669 |
| 115 | Alopecia of scalp (HP:0002293) | 2.14252544 |
| 116 | Bundle branch block (HP:0011710) | 2.13060513 |
| 117 | J-shaped sella turcica (HP:0002680) | 2.12488963 |
| 118 | Hypoglycemic seizures (HP:0002173) | 2.11904184 |
| 119 | Sensorimotor neuropathy (HP:0007141) | 2.10324204 |
| 120 | Upper limb amyotrophy (HP:0009129) | 2.10171425 |
| 121 | Distal upper limb amyotrophy (HP:0007149) | 2.10171425 |
| 122 | Rhabdomyolysis (HP:0003201) | 2.09890583 |
| 123 | Systemic lupus erythematosus (HP:0002725) | 2.09842186 |
| 124 | Ragged-red muscle fibers (HP:0003200) | 2.08471565 |
| 125 | Round ear (HP:0100830) | 2.08368335 |
| 126 | Pancreatitis (HP:0001733) | 2.07783795 |
| 127 | Achilles tendon contracture (HP:0001771) | 2.04218030 |
| 128 | Exercise-induced myalgia (HP:0003738) | 2.03762149 |
| 129 | Lymphangioma (HP:0100764) | 2.01929366 |
| 130 | Exercise-induced muscle cramps (HP:0003710) | 2.01095403 |
| 131 | Enlarged kidneys (HP:0000105) | 2.00066999 |
| 132 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.99697697 |
| 133 | Esophageal varix (HP:0002040) | 1.98099105 |
| 134 | Scapular winging (HP:0003691) | 1.97111847 |
| 135 | Polycythemia (HP:0001901) | 1.96580255 |
| 136 | Acute hepatic failure (HP:0006554) | 1.94223715 |
| 137 | Metaphyseal cupping (HP:0003021) | 1.93954168 |
| 138 | Rickets (HP:0002748) | 1.93868693 |
| 139 | Hyperacusis (HP:0010780) | 1.93551268 |
| 140 | Lower limb amyotrophy (HP:0007210) | 1.93002432 |
| 141 | Ventricular fibrillation (HP:0001663) | 1.92979462 |
| 142 | Hemorrhage of the eye (HP:0011885) | 1.92902943 |
| 143 | Brushfield spots (HP:0001088) | 1.92104087 |
| 144 | Opisthotonus (HP:0002179) | 1.91854571 |
| 145 | Foot dorsiflexor weakness (HP:0009027) | 1.89928281 |
| 146 | Abnormal atrioventricular conduction (HP:0005150) | 1.88090949 |
| 147 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.87908169 |
| 148 | Nephritis (HP:0000123) | 1.87431086 |
| 149 | Abnormal cartilage morphology (HP:0002763) | 1.87228141 |
| 150 | Hypertriglyceridemia (HP:0002155) | 1.87213102 |
| 151 | Glycosuria (HP:0003076) | 1.87045028 |
| 152 | Abnormality of urine glucose concentration (HP:0011016) | 1.87045028 |
| 153 | Calf muscle hypertrophy (HP:0008981) | 1.85341364 |
| 154 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.84656360 |
| 155 | Nausea (HP:0002018) | 1.84488366 |
| 156 | Mitral stenosis (HP:0001718) | 1.83622620 |
| 157 | Amyloidosis (HP:0011034) | 1.81256011 |
| 158 | Renal cortical cysts (HP:0000803) | 1.80788721 |
| 159 | EMG: neuropathic changes (HP:0003445) | 1.80186348 |
| 160 | Aneurysm (HP:0002617) | 1.79087551 |
| 161 | Ventricular arrhythmia (HP:0004308) | 1.78467661 |
| 162 | Advanced eruption of teeth (HP:0006288) | 1.77427625 |
| 163 | Dilated cardiomyopathy (HP:0001644) | 1.76280822 |
| 164 | Abnormality of the foot musculature (HP:0001436) | 1.75371381 |
| 165 | Abnormality of the gallbladder (HP:0005264) | 1.73712595 |
| 166 | Nuclear cataract (HP:0100018) | 1.71188274 |
| 167 | Status epilepticus (HP:0002133) | 1.71105158 |
| 168 | Ulnar deviation of the wrist (HP:0003049) | 1.69747257 |
| 169 | Protrusio acetabuli (HP:0003179) | 1.69541000 |
| 170 | Heart block (HP:0012722) | 1.68010019 |
| 171 | Disproportionate tall stature (HP:0001519) | 1.67558371 |
| 172 | Generalized amyotrophy (HP:0003700) | 1.64968691 |
| 173 | Onion bulb formation (HP:0003383) | 1.64282329 |
| 174 | Dysostosis multiplex (HP:0000943) | 1.63722062 |
| 175 | Biconcave vertebral bodies (HP:0004586) | 1.62391975 |
| 176 | Neonatal death (HP:0003811) | 1.62317926 |
| 177 | Syncope (HP:0001279) | 1.60984581 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.68592611 |
| 2 | ICK | 3.55998456 |
| 3 | SIK1 | 3.37546679 |
| 4 | MAPK15 | 3.07882391 |
| 5 | PINK1 | 3.02160606 |
| 6 | FGFR4 | 2.82302941 |
| 7 | ERN1 | 2.73525439 |
| 8 | EPHA2 | 2.73410011 |
| 9 | TRIB3 | 2.68009782 |
| 10 | EEF2K | 2.34932150 |
| 11 | MAP3K6 | 2.30148426 |
| 12 | PDK4 | 2.25915602 |
| 13 | PDK3 | 2.25915602 |
| 14 | DDR2 | 2.07701163 |
| 15 | IRAK3 | 1.86264878 |
| 16 | MAP3K11 | 1.84719302 |
| 17 | MAPK11 | 1.72470231 |
| 18 | INSRR | 1.66744787 |
| 19 | SMG1 | 1.66719113 |
| 20 | PHKG2 | 1.61252766 |
| 21 | PHKG1 | 1.61252766 |
| 22 | RIPK1 | 1.51510901 |
| 23 | WNK4 | 1.50045999 |
| 24 | LATS1 | 1.47601878 |
| 25 | TYRO3 | 1.45597384 |
| 26 | ERBB4 | 1.43384019 |
| 27 | PDGFRA | 1.40639773 |
| 28 | DYRK1B | 1.40477012 |
| 29 | MST1R | 1.39419848 |
| 30 | STK38L | 1.35950770 |
| 31 | PDK2 | 1.34815219 |
| 32 | CAMK1D | 1.33993203 |
| 33 | PRKAA2 | 1.32161647 |
| 34 | PRPF4B | 1.31219550 |
| 35 | WNK3 | 1.28684335 |
| 36 | TNK2 | 1.28281995 |
| 37 | PKN2 | 1.26422793 |
| 38 | TAOK1 | 1.25398795 |
| 39 | MAP3K1 | 1.24428476 |
| 40 | MARK2 | 1.23906693 |
| 41 | CSK | 1.22445166 |
| 42 | MAP2K4 | 1.14492126 |
| 43 | BMX | 1.13975379 |
| 44 | MAP3K13 | 1.13813978 |
| 45 | PRKAA1 | 1.12996329 |
| 46 | FGFR2 | 1.10839348 |
| 47 | TESK1 | 1.09819453 |
| 48 | GSK3A | 1.07549604 |
| 49 | NME2 | 1.04851685 |
| 50 | MARK3 | 1.03996437 |
| 51 | LATS2 | 0.97316571 |
| 52 | PRKD2 | 0.95920587 |
| 53 | CDK6 | 0.94219038 |
| 54 | FGR | 0.93811431 |
| 55 | MATK | 0.93807124 |
| 56 | KSR2 | 0.93664220 |
| 57 | MAP3K7 | 0.92675203 |
| 58 | OXSR1 | 0.90682601 |
| 59 | STK38 | 0.87597089 |
| 60 | CDK12 | 0.84716100 |
| 61 | DAPK2 | 0.84655962 |
| 62 | EPHB1 | 0.84580744 |
| 63 | FLT3 | 0.84121516 |
| 64 | LMTK2 | 0.83853850 |
| 65 | MUSK | 0.82461139 |
| 66 | DMPK | 0.82192842 |
| 67 | TIE1 | 0.81455878 |
| 68 | PTK6 | 0.81421343 |
| 69 | MAP3K3 | 0.79802330 |
| 70 | CAMK2G | 0.79749539 |
| 71 | RIPK4 | 0.79004626 |
| 72 | TTN | 0.78595142 |
| 73 | PIK3CG | 0.77611000 |
| 74 | CAMK1G | 0.77299437 |
| 75 | DAPK1 | 0.74275881 |
| 76 | RPS6KA2 | 0.74020645 |
| 77 | JAK2 | 0.72737796 |
| 78 | TBK1 | 0.72678714 |
| 79 | MTOR | 0.69720123 |
| 80 | MET | 0.69285783 |
| 81 | MAPK4 | 0.68444842 |
| 82 | PRKG2 | 0.68410637 |
| 83 | MAP3K10 | 0.68380125 |
| 84 | ZAP70 | 0.68204766 |
| 85 | PAK4 | 0.67772978 |
| 86 | PRKACG | 0.67763032 |
| 87 | PRKCZ | 0.67613505 |
| 88 | TAOK3 | 0.67593077 |
| 89 | NME1 | 0.67431693 |
| 90 | PRKD3 | 0.66478632 |
| 91 | OBSCN | 0.65308272 |
| 92 | BLK | 0.64487633 |
| 93 | MAP4K1 | 0.62738794 |
| 94 | MAP2K3 | 0.61539995 |
| 95 | ABL2 | 0.61298054 |
| 96 | NEK1 | 0.61156325 |
| 97 | MAPK12 | 0.59912409 |
| 98 | PTK2 | 0.59837232 |
| 99 | ARAF | 0.56711846 |
| 100 | KDR | 0.55590783 |
| 101 | IRAK2 | 0.53868393 |
| 102 | CDC42BPA | 0.53847766 |
| 103 | TYK2 | 0.53611721 |
| 104 | PDPK1 | 0.53208556 |
| 105 | PRKD1 | 0.52769165 |
| 106 | RET | 0.51681520 |
| 107 | ERBB2 | 0.51055101 |
| 108 | SGK3 | 0.49675812 |
| 109 | PDK1 | 0.49531122 |
| 110 | MAP3K2 | 0.49431839 |
| 111 | MYLK | 0.48908338 |
| 112 | TAOK2 | 0.48493873 |
| 113 | FGFR3 | 0.46854458 |
| 114 | RPS6KL1 | 0.44730180 |
| 115 | RPS6KC1 | 0.44730180 |
| 116 | NEK2 | 0.44652483 |
| 117 | ROCK1 | 0.44098994 |
| 118 | TGFBR2 | 0.42636950 |
| 119 | STK39 | 0.40119077 |
| 120 | MAP3K8 | 0.38886009 |
| 121 | RPS6KA1 | 0.38276016 |
| 122 | GRK6 | 0.36486492 |
| 123 | MAPK7 | 0.36352235 |
| 124 | JAK3 | 0.36121680 |
| 125 | RPS6KA6 | 0.36076014 |
| 126 | MAP2K6 | 0.35208489 |
| 127 | MAPKAPK2 | 0.33240059 |
| 128 | JAK1 | 0.33148255 |
| 129 | FER | 0.33050520 |
| 130 | HIPK2 | 0.32667112 |
| 131 | MAP2K1 | 0.32569833 |
| 132 | AKT3 | 0.31628200 |
| 133 | SGK223 | 0.31570568 |
| 134 | SGK494 | 0.31570568 |
| 135 | MAPKAPK3 | 0.31064597 |
| 136 | PDGFRB | 0.29998045 |
| 137 | EGFR | 0.29418028 |
| 138 | CAMK4 | 0.28918779 |
| 139 | TRPM7 | 0.28499653 |
| 140 | NEK9 | 0.27933587 |
| 141 | PAK3 | 0.27873106 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.83622110 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.17279160 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.14530150 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.96144299 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.93013445 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.84668375 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.76735946 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.75434364 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.70384111 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.66528020 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.56200491 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.56074162 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.54244007 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.37936169 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.34111595 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.27846042 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.23488097 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.19923647 |
| 19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.12432904 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 2.10619207 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.84120301 |
| 22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.79513903 |
| 23 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.79054400 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77882635 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.68666401 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.63947792 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.63279828 |
| 28 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.61657740 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.56089538 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.55701391 |
| 31 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.53395893 |
| 32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.50554266 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.49043411 |
| 34 | Carbon metabolism_Homo sapiens_hsa01200 | 1.48468216 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.46864660 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.44373289 |
| 37 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.42901032 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.42767432 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.38727154 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.38150264 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.36440707 |
| 42 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.33375494 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.29985319 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29254182 |
| 45 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.22228991 |
| 46 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.21434211 |
| 47 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.21288214 |
| 48 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.19621799 |
| 49 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.18531775 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.18037104 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17703349 |
| 52 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.17578549 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 1.14195594 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.14165677 |
| 55 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.11448265 |
| 56 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.09596035 |
| 57 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.08592841 |
| 58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.07452572 |
| 59 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.03784664 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 1.03390559 |
| 61 | Sulfur relay system_Homo sapiens_hsa04122 | 1.00028490 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94170666 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89053930 |
| 64 | Focal adhesion_Homo sapiens_hsa04510 | 0.87335178 |
| 65 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.87292561 |
| 66 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.86183295 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83159600 |
| 68 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.80519108 |
| 69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77633866 |
| 70 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.76054405 |
| 71 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.74051314 |
| 72 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.73459396 |
| 73 | Amoebiasis_Homo sapiens_hsa05146 | 0.69727669 |
| 74 | Pertussis_Homo sapiens_hsa05133 | 0.67446649 |
| 75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67215346 |
| 76 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66627341 |
| 77 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.61051631 |
| 78 | * Glutathione metabolism_Homo sapiens_hsa00480 | 0.60542233 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.60367540 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59498542 |
| 81 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58280941 |
| 82 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57302134 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56528049 |
| 84 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.56328992 |
| 85 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.53816958 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.53213160 |
| 87 | Lysosome_Homo sapiens_hsa04142 | 0.52715277 |
| 88 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.52445330 |
| 89 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50191864 |
| 90 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48182403 |
| 91 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.47152619 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46890426 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45721154 |
| 94 | Gap junction_Homo sapiens_hsa04540 | 0.44370197 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42290020 |
| 96 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41588938 |
| 97 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.41375581 |
| 98 | Tight junction_Homo sapiens_hsa04530 | 0.41091418 |
| 99 | Apoptosis_Homo sapiens_hsa04210 | 0.40751357 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39489714 |
| 101 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.38859674 |
| 102 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38346350 |
| 103 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37227465 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.37108684 |
| 105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36170185 |
| 106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36169861 |
| 107 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.35939583 |
| 108 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.35501979 |
| 109 | Thyroid cancer_Homo sapiens_hsa05216 | 0.35435335 |
| 110 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.34998250 |
| 111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34902484 |
| 112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.33557430 |
| 113 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33218965 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.30386891 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27001794 |
| 116 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.26043044 |
| 117 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.24571837 |
| 118 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20332899 |
| 119 | Prion diseases_Homo sapiens_hsa05020 | 0.19884187 |
| 120 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.18129030 |
| 121 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.13329053 |
| 122 | Circadian rhythm_Homo sapiens_hsa04710 | 0.11870999 |
| 123 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.04235887 |
| 124 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.01161858 |
| 125 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1580529 |
| 126 | Alzheimers disease_Homo sapiens_hsa05010 | -0.1547559 |
| 127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.1493535 |
| 128 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1307605 |
| 129 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1296161 |
| 130 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1271747 |
| 131 | Parkinsons disease_Homo sapiens_hsa05012 | -0.1207221 |
| 132 | Bladder cancer_Homo sapiens_hsa05219 | -0.1152156 |
| 133 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1093615 |
| 134 | Cardiac muscle contraction_Homo sapiens_hsa04260 | -0.0995168 |
| 135 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0864583 |
| 136 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0784540 |
| 137 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0691963 |
| 138 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0399912 |
| 139 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0359801 |
| 140 | Mineral absorption_Homo sapiens_hsa04978 | -0.0104739 |
| 141 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0079657 |

